The aim of this work was to study release of glutamic acid (GLU) from one-axon terminal or bouton at-a-time using cortical neurons grown in vitro to study the effect of presynaptic autoand heteroreceptor stimulation. Neurons were infected with release reporters SypHx2 or iGluSnFR at 7 or 3 days-in-vitro (DIV) respectively. At 13-15 DIV single synaptic boutons were identified from images obtained from a confocal scanning microscope before and after field electrical stimulation. We further stimulated release by raising intracellular levels of cAMP with forskolin (10 mM). Forskolin-mediated effects were dependent on protein kinase A (PKA) and did not result from an increase in endocytosis, but rather from an increase in the size of the vesicle readily releasable pool. Once iGluSnFR was confirmed as more sensitive than SypHx2, it was used to study the participation of presynaptic auto-and heteroreceptors on GLU release. Although most receptor agonizts (carbamylcholine, nicotine, dopamine D2, BDNF) did not affect electrically stimulated GLU release, a significant increase was observed in the presence of metabotropic D1/D5 heteroreceptor agonist (SKF38393 10 mM) that was reversed by PKA inhibitors. Interestingly, stimulation of group II metabotropic mGLU2/3 autoreceptors (LY379268 50 nM) induced a decrease in GLU release that was reversed by the specific mGLU2/3 receptor antagonist (LY341495 1 mM) and also by PKA inhibitors (KT5720 200 nM and PKI14-22 400 nM). These changes in release probability at individual release sites suggest another level of control of the distribution of transmitter substances in cortical tissue.
Introduction
Activation of presynaptic auto-and heteroreceptors contribute to neurotransmitter release by sensing the local presence of neurotransmitter to either inhibit or promote further release.
Cortical output neurons are presynaptically modulated by GLU autoreceptors and heteroreceptors to a plethora of neurotransmitters. Although the presence of presynaptic receptors is required, a direct presynaptic input is not. Volume transmis- receptors, which include NMDA, AMPA and kainate receptors, and metabotropic receptors (mGluRs) which couple via Gproteins to intracellular second messenger signaling pathways. Presynaptic modulation of GLU release by activation of ionotropic or metabotropic (mGLUR) receptors has been well documented (Garcia-Munoz et al., 1991a , 1991b Lovinger et al., 1993; Maura et al., 1988; Nicholls, 1998; O'Donnell and Grace, 1994; West and Grace, 2002) to quote just a few. Depending on the nucleotide sequence of genes mGLURs are classified into 3 groups: mGLURs 1 and 5 (group I), mGLURs 2 and 3 (group II) and mGLURs 4, 6, 7 and 8 (group III) . Groups II and III are usually found in presynaptic terminals as autoreceptors (Williams and Dexter, 2014) . Since mGLURs have approximately 10-fold higher affinity for GLU than ionotropic receptors (Gerber, 2003) their location as sensors of presynaptic release has been considered ideal (Miller, 1998) . Evidence of modulation of GLU release by activation of heteroreceptors in cortical terminals has also been given for GABA (Logie et al., 2013; Waldmeier et al., 2008) , acetylcholine (Giocomo and Hasselmo, 2007; Pancani et al., 2014) , dopamine (Bamford et al., 2004; Cepeda et al., 2001) , noradrenaline (Luo et al., 2014a (Luo et al., , 2014b , adenosine (Bannon et al., 2014; Quiroz et al., 2009) ; somatostatin (Grilli et al., 2004) ; cholecystokinin (Deng et al., 2006) ; endocannabinoids (Ferreira et al., 2012; Lemtiri-Chlieh and Levine, 2010; Perez-Rosello et al., 2013) and serotonin (Aghajanian and Marek, 1999; Calcagno et al., 2006 Calcagno et al., , 2009 Wang et al., 2006) .
Apart from the effects of neurotensin receptor activation that appear to be indirectly mediated by the induced release of another neurotransmitter (Ferraro et al., 2008; Matsuyama et al., 2003; Yin et al., 2008) , direct modulation of cortical GLU release resulting from auto-and heteroreceptor stimulation typically occurs by stimulation of secondary intraterminal cascades the simplest of which is the facilitation of calcium entrance, by ionotropic GLU receptor induced depolarization, that favors vesicle release (Perkinton and Sihra, 1999) . Stimulation of G-protein coupled metabotropic auto-and heteroreceptors leads to activation of intracellular signal transduction pathways targeting a variety of intracellular proteins including protein kinases. A second messenger such as calcium or cAMP typically regulates the activity of protein kinases. Protein kinase A (PKA) and protein kinase C (PKC) are associated with modulation of neurotransmitter release.
Studies of presynaptic events, such as those reported above, have used a variety of methods to detect endogenous release; stimulated release of preloaded neurons or synaptosomes, microdialysis, postsynaptic intracellular recordings of spontaneous and miniature depolarizing potentials or postsynaptic currents following pair-pulse stimulation. Those methods provide valuable data but in general their disadvantage is the large population of synapses involved. Although our basic knowledge about transmitter release is largely based on the much simpler and more robust neuromuscular junction, central synapses seem to have different properties the most striking of which is the intermittent nature of release from individual boutons. Methods recently available that use optical reporters of exocytosis allow the precise study of release at single boutons. In view of the variety of modulatory influences on cortical GLU release we decided to use two optical release reporters, synaptophysin-pHlourinx2 (SypHx2) and intensity-based GLU-sensing fluorescent reporter (iGluSnFR). SypHx2 is the fusion of synaptic vesicle protein synaptophysin with two molecules of the super ecliptic pHluorin, pH-sensitive green fluorescent protein (GFP) (Burrone et al., 2006; Zhu et al., 2009) , iGluSnFR is a sensor for synaptically released GLU constructed using a bacterial periplasmic binding protein and circularly permutated GFP (Marvin et al., 2013) . We first studied release and compared the sensitivity of the two reporters using cortical neurons grown in vitro and stimulated the production of cAMP with forskolin. Since cortical neuron synapses are smaller than those typically used in release studies (i.e., hippocampal or cerebellar) the sensitive iGluSnFR reporter proved superior to SypHx2 for the study of the effect of presynaptic receptors stimulation on facilitated release. iGluSnFR had a higher signal-to-noise ratio and detected release after only a single pulse of electrical field stimulation. The effect of specific presynaptic receptor stimulation before and after drug administration allowed us to detect changes in release at the level of single boutons. Here we report a major enhancing effect on GLU release at individual boutons induced by dopamine D1/D5 receptor stimulation and an inhibitory effect induced by a group II mGLU2/3 agonist. Both specific hetero-and autoreceptor-mediated effects were reversed by PKA antagonists. In summary, our results confirm presynaptic auto-and heteroreceptor modulation of single pulse-induced GLU release in individual synaptic boutons en passage of cortical neurons grown in vitro dependent on the AC/PKA pathway.
Results
The study of neurotransmitter release was significantly advanced by the use of synaptopHluorin (SypHx2), a fluorescent protein designed to detect vesicle fusion at the synapse. To detect the pH change that occurs along neurotransmitter release a particularly pH-sensitive variant of green fluorescent protein, ecliptic pHluorin, was fused to the vesicular protein synaptobrevin. Once transfected and expressed, pHluorin is quenched in the acidic lumen of vesicles (pH$5.5) and increases fluorescence about 20-fold after fusion with the plasma membrane. This reporter has been invaluable for the study of changes in neurotransmitter release (Balaji and Ryan, 2007; Gandhi and Stevens, 2003; Zhu et al., 2009) . As is typical for this reporter, SypHx2 signal is optimal above 5 action potentials at 20 Hz (Gandhi and Stevens, 2003; Zhu et al., 2009 ). The iGluSnFR sensor for synaptically released GLU is produced under the synapsin promoter and uses the periplasmic binding-proteindependent transport system for GLU and aspartate to anchor the protein to the extracellular plasma membrane. The binding of GLU to this periplasmic protein induces a conformational change in an inserted circularly permuted green fluorescent protein. The advantage of this reporter is that fluorescence can be detected in response of a single stimulus (Marvin et al., 2013) . In our cultures, two weeks after transduction cortical neurons expressed either the SypHx2 or iGluSnFR sensor. To report release neurons expressing SypHx2 required five action potentials at 20 Hz (20 mA/1ms, A-iGlUSnFR was expressed on the extracellular surface of the postsynaptic membrane. The postsynaptic marker PSD-95 overlapped with iGluSnFR in some pucta as clearly seen in image with red frame. B-SynHx2 expression on presynaptic boutons was confirmed by its overlap with vGlut-1 as seen in the image with the red frame. iGluSnFR did not appear in presynaptic VGlut1 marked boutons and SypHx2 was adjacent to PSD95 pucta.
repeated 10 times every 5 s) whereas in neurons expressing iGluSnFR a single electrical pulse (20 mA/1ms, repeated 4 times every 10 s) was sufficient to produce a fluorescent signal large enough to be detected above noise. However, the iGluSnFR signal saturated with 5 pulses (Fig. 1) .
As expected according to the expression sites for each reporter, immunohistochemical analyses with antibodies to postsynaptic density protein 95 (PSD-95) or vesicular GLU transporter 1 (vGlut-1) showed that SypHx2 was located presynaptically whereas iGluSnFR was expressed in postsynaptic membranes dendrites and spines probably at synaptic and extrasynaptic sites (Fig. 2) . However, the presence of neither reporter alone was sufficient to identify synapses, and so we identified release sites at the end of the experiment in every case by following release from high frequency stimulation. Release sites identified in this manner often do not release in the milder conditions of our experiments. They therefore are likely to have low probability of release in the resting state of our cultures. Such a state is common in central synapses generally. This interpretation is supported by the increase in the number of release sites detected when the extracellular calcium concentration was doubled to 5 mM. In 2.5 mM Ca þþ 9.9473.9% (n¼ 277 boutons; 5 different cultures) and in 5 mM Ca þþ 26.2773.7% (n¼ 251 boutons; 3 different cultures). Our primary pharmacological tool to stimulate release was forskolin since it is known to increase the probability of release by activation of adenylate cyclase and protein kinase A (Ariel et al., 2012; Chavez-Noriega and Stevens, 1992; Chen and Regehr, 1997; Crawford and Mennerick, 2012; Kaneko and Takahashi, 2004; Trudeau et al., 1996) . Many of the synapses were not releasing before the drug application but could be recognized after the event when a final train of high intensity and high frequency pulses elicited release from many synaptic areas (release was measured as a difference in the average fluorescence change, induced by standard stimulation, before and after drugs in a 1 mm circular region of interest centered on the release site,-see methods section 4.6.1). The effect of forskolin (10 mM) as studied with SypHx2 (n¼ 204 boutons; 6 different cultures, 31.3375.6% increase of which 1.270.6% was from 129 previously active synapses) and with iGluSnFR (n¼ 323 boutons; 4 different cultures; 42.175.6%, po0.03 increase of which 4.270.8% was contributed by 75 previously active synapses) was mediated by cAMP-dependent PKA pathway since, in the presence of PKA inhibitor KT5720, release was not potentiated beyond control levels (7.970.4% for SypHx2 n¼ 88; 15.470.4% for iGluSnFR n¼ 341 boutons; 4 different cultures each). KT5720 by itself did not significantly modify release (7.973.5% 161 synapses in 5 dishes p40.6). In order to separate possible different intracellular mechanisms between PKA and exchange protein activated by cAMP (epac) we used a selective agonist of epac, 8-CPT-2'-Ome-cAMP (100 mM) and the activator of both PKA and epac, 8-Br-cAMP (Christensen et al., 2003) . The effect of the selective epac agonist, 8-CPT-2'-O-me-cAMP was not statistically different from controls excluding therefore the participation of epac in the release we measured. As expected, the cAMP analog 8-Br-cAMP (100 μM) resulted in an increase in release (215 boutons, 5 different cultures, 34.677.0%, po0.01, ANOVA and Newman-Keuls test). Fig. 3 illustrates the changes induced by forskolin using both release reporters on responsive and unresponsive synapses.
To explain the causes of activation of synapses in the presence of forskolin we first determined if it modified endocytosis. As indicated in the methods (section 4.6.3) we measured endocytosis by measuring the decay of the reported fluorescence following high frequency stimulation since the falling phase of ΔSypHx2 signals after stimulation reflects the speed of the endocytosis of synaptic vesicles (Atluri and Ryan, 2006; Granseth et al., 2006) . The time constant of falling phase of ΔSypHx2 signal before (no drug) 14.670.88 s n¼ 62 and after forskolin 14.8670.85 s n ¼88 did not differ (p40.86, paired t-test). To establish if the mechanisms underlying calcium-dependent release were affected by forskolin in our cortical neurons we used the single-wavelength genetically encoded calcium indicator GCaMP3 and observed that, consistent with findings obtained in cerebellar and hippocampal neurons (Crawford and Mennerick, 2012) , the ratio of change in ΔGCaMP3 signal amplitude before and after forskolin was not significantly different (0.2270.03 versus 0.2570.03, p40.22, n ¼149 boutons, paired t-test). Since the effects of forskolin were not explained by a change intracellular calcium or endocytocis we studied modifications on the readily releasable pool (RRP) (Ariel and Ryan, 2010) and observed a significant increase after forskolin in 48 boutons becoming active (3 different cultures) but not in the 123 already active ones (3 different cultures) (Fig. 4) . Results that are congruent with observed activity-related changes in vesicle recruitment (Brown and Sihra, 2008) . In spite of not detecting changes in the average RRP; initially-responsive boutons did respond to forskolin by increasing their release (1.270.6% for SynpHx2 and 4.270.8% in experiments with iGuSnFR)
Once we corroborated that forskolin activated individual synapses in our cortical neurons we examined the mechanism by which activation of the AC/PKA pathway led to activation of silent cortical synapses. We had inhibited ionotropic glutamate actions with DNQX and so the presence of presynaptic neurotransmitter receptors was an obvious choice. Stimulation of acetylcholine heteroreceptors with nicotine (1 mM, 231 boutons 2 different cultures) did not modify electrically stimulated release. Administration of dopamine D2 heteroreceptor agonist (7)-quinpirole (0.5 mM, 197 boutons 3 different cultures) did not modify stimulated GLU release, but the D1/D5 heteroreceptor agonist SKF38393 (10 mM) induced a significant increase in release (24.2874.5% 16% n¼ 402 synaptic boutons, 4 different cultures). Similar to the effect of forskolin, previously unresponsive boutons (91) began to release following SKF38393 and 157 previously active boutons increased their release by 6.570.4%. After administration of SKF38393 a clear increase in number of responsive synapses was also seen in neurons expressing iGluSnFR reporter (Fig. 5 A) . Neither reporter detected any changes in unstimulated fluorescence, perhaps because of the postsynaptic blockade of spontaneous activity with DNQX. The significant conversion of inactive to active synapses that was observed after the D1/D5 agonist was reversed by protein kinase A inhibitors KT5720 (n ¼291, 3 different cultures) and PKI14-22 (n¼ 318, 3 different cultures) (Fig. 5B ).
Since presynaptic mGluR2/3 activation reduces neurotransmitter release at CNS synapses (Robbe et al., 2002) and silencing of synapses is observed after sustained stimulation of presynaptic adenosine A1 and GABAB receptors in hippocampal culture neurons (Crawford and Mennerick, 2012) our next question was whether the activation of group 2/3 mGLU autoreceptors in cortical neurons could change the numbers of synapses activated. As illustrated in Fig. 6A , administration of selective group 2/3 mGluR agonist, LY379268 (50 nM) eliminated all fluorescent signals in response to stimulation, from iGluSnFR transfected neurons.
Overlapped average fluorescent signals before and after LY379268 also show this depressive effect (Fig. 6B) . The percentage decrease of previously active synapses following drug administration was 37.7174.8% (Fig. 6C) . Almost as many previously active synapses reduced their release; 157 were reduced while 115 silenced completely. To determine if the effect of LY379268 depended on actions of PKA, we applied the specific inhibitors, KT5720 (200 nM) or PKI 14-22 (400 nM). In the presence of these PKA inhibitors the release elicited in the presence of LY379268 reverted to typical control values (Fig. 6C ) (ANOVA and Newman-Keuls test ***po0.005, **po0.01, *po0.03, LY379268 n¼ 354, 6 different cultures; LY379268þPKI14-22 n ¼236, 4 different cultures; LY379268þLY341495 n¼ 155, 3 different cultures). In contrast, antagonism of GABAB receptors with CGP55845 (500 nM; 396 synapses 3 different cultures) or SCH50911 (10 mM; 256 synapses 2 different cultures) did not modify stimulated release.
Discussion
Here we report opposite effects on electrically induced GLU release by presynaptic dopamine D1 and GLU mGLU2/3 receptor agonists (Figs. 5 and 6). A higher sensitivity of iGluSnFR over SypHx2 was determined by using the typical potentiation of release induced by forskolin (Ariel et al., 2012; Chavez-Noriega and Stevens, 1992; Chen and Regehr, 1997; Crawford and Mennerick, 2012; Kaneko and Takahashi, 2004; Trudeau et al., 1996) (Figs. 1 and 2). As reported by others (Chen and Regehr, 1997) forskolin-mediated increase in GLU release was not dependent on intracellular calcium levels. We confirmed that forskolin-induced increase in release did not result from an increase in endocytosis, but rather from an increase in the size of the RRP in the inactive boutons activated by forskolin (Fig. 4) . Individual synaptic variability in the size of the RRP (Ariel et al., 2012) could be related to the response of previously inactive boutons to forskolin (Chavis et al., 1998; Tong et al., 1996) . The identity of target neurons and the local environment around the synapse most likely influence neuronal presynaptic receptor expression and release characteristics. An advantage of working with neurons grown in vitro is that some of these variables are restricted. Our results indicate that in spite of lack of long-range input and output targets, neurons in culture express presynaptic receptors that control their release. Although such preparations are subject to homeostatic plasticity that has been a source of silenced synapses we worked with the normal variation in release probability in untreated cultures. Moreover, the observed changes in the number of active boutons following forskolin (Fig. 3) and presynaptic receptor activation (Figs. 5 and 6 ) indicate an important contribution of presynaptic receptors to plasticity, even though we blocked the normal postsynaptic activity with DNQX in the perfusion solution.
Although the reported inactive synapses were stable over the course of our experiments it is possible that over physiological time scales in vivo they may just be the consequence of the stochastic release process known to be common in boutons "en passage" in other areas of the brain.
3.1.
Modulation of glutamate release by presynaptic dopamine D1 receptors
The postsynaptic influence of dopamine on cortical functions such as attention, motivation, appetite and memory (Cools and D'Esposito, 2011; Fan et al., 2014; Marazziti et al., 2013; Michaelides et al., 2012; Palmiter, 2011) and several pathologies such as schizophrenia, depression, drug addiction and attention deficits (Arnsten, 2009; Chen and Yang, 2002; Duman and Voleti, 2012; Russo and Nestler, 2013) has reinforced the idea of a close presynaptic and postsynaptic dopamine/GLU collaboration.
Presynaptic receptors fine-tune release activity at synapses. Reciprocal interaction between dopamine and GLU involving presynaptic auto-and heteroreceptors takes place at convergent axonal terminal fields in prefrontal cortex and sites of cortical input to striatum and nucleus accumbens (French and Totterdell, 2002; Johnson et al., 1994; Pickel, 1990, 1992; Totterdell and Smith, 1989) . Of the several dopaminergic systems in the brain, the mesencephalic areas A8, A9 and A10 innervate cortical neurons and areas where these neurons send axons (e.g. striatum, hippocampus and amygdala) (Dahlstrom and Fuxe, 1964) . Presynaptic D1 and D2 receptors are present on cortical and basal ganglia GLU-containing terminals ( receptors in a decrease in GLU release is well established (Carli and Invernizzi, 2014; Ferraro et al., 2012; Flores-Hernandez et al., 1997; Garcia-Munoz et al., 1991a; Hsu et al., 1995; Maura et al., 1988; Nicholls, 1998; O'Donnell and Grace, 1994) . Facilitation of GLU release by specific activation of D1 receptors was more difficult to establish. Electrophysiological studies were the first to indicate that dopamine D1 and D2 receptor agonists had opposite actions in postsynaptic membrane excitability (Cepeda et al., 1992 (Cepeda et al., , 2001 Chu et al., 2010; Hernandez et al., 2007; Seamans and Yang, 2004; West and Grace, 2002) . Differential responses according to dopamine concentration (Zheng et al., 1999) or striatal neuronal type (direct and indirect output neurons) (Andre et al., 2010) have also been reported.
Studies of the direct effect of D1 receptor stimulation on GLU release are few (Abekawa et al., 2000; Bouron and Reuter, 1999 
Presynaptic group II metabotropic glutamate autoreceptors
It has been established that one of the physiological effects of group II mGluRs is to negatively modulate neurotransmitter release from nerve endings that express 2/3 mGluRs as autoreceptors (Bushell et al., 1996; Conn and Pin, 1997; Raiteri, 2008; Romei et al., 2013) or as heteroreceptors in terminals releasing GABA (Petralia et al., 1996; Schaffhauser et al., 1998) . Here we report a decrease in electrically stimulated GLU release and an associated conversion of responsive to inactive synapses (Fig. 6) . It remains to be established if the plastic effect of inactivating synapses lasts long enough to possibly have an enduring therapeutic effect in pathological states of hyperactive glutamatergic synapses such as epilepsy or schizophrenia (Hiyoshi et al., 2014) . Although long term changes as a result of mGluR activation have been reported and those are also inhibited by PKA the final action of the presynaptic receptors seems likely to be via voltage gated calcium channels in the terminals. Indeed, in some experiments these seem to be the dominant effectors, in others the calcium channels are modified by PKA actions consequent upon the mGluR activation. Since the effects seem to depend on the site in brain that is investigated as well as the time course of the effect studied we have no definitive experiments to decide the molecular site of action in our cultures.
3.3.
Consequence of presynaptic receptor activation on release at individual synapses Much research related to synaptic strength concentrates on activity-dependent alterations produced by modifications either in synaptic efficacies or synaptic wiring e.g., (Chklovskii et al., 2004) . Silent presynaptic synapses also described as mute, inactive or dormant, do not release neurotransmitter until certain activity dependent modifications are achieved. They have been described for excitatory and inhibitory neurotransmitters and have been observed in invertebrates (e.g., snail, aplysia, drosophila) and vertebrates (e.g., fish and mammals) (Doussau et al., 2010; Kim et al., 2003; Massobrio et al., 2013; Peled and Isacoff, 2011) . Under particular network demands they are activated or awakened representing what has been described as "a golden reserve for plasticity" . The synapses in our study were not active at rest and not during the experimental stimulation in the absence of activation by drugs. We identified them by their response to stronger stimulation at the end of the experiment suggesting that they had a high threshold for release perhaps because of a low probability of vesicular release. Typically, an increase in synaptic efficacy is accompanied by an increase in presynaptic neurotransmitter release, an increase in postsynaptic receptor efficacy or both. Here we report that in the presence of forskolin, previously unresponsive boutons became active ( Fig. 3) with an associated increase in the size of readily releasable pool (Fig. 4) . Importantly, we report that specific activation of dopamine D1/D5 receptors also produced an activating effect (Fig. 5) , whereas stimulation of presynaptic group II mGlu2/3 receptors reduced the number of responsive synapses (Fig. 6) . In both cases inhibitors of PKA reversed the "unresponsive to active" or "active to unresponsive" consequences of presynaptic receptor stimulation. In contrast to areas like hippocampal mossy fiber synapses or Calyx of Held (Kaneko and Takahashi, 2004) activation of the alternative cAMP activated Epac pathway did not have any effect on the number of activated synapses (Fig. 3) .
There is ample evidence for postsynaptic silent synapses on cortical and hippocampal neurons dependent on the presence and function of NMDA receptors but not AMPA receptors. These silent synapses become active following induction of LTP and postsynaptic insertion of functional AMPA receptors (Kerchner and Nicoll, 2008) . A pre-and postsynaptic mechanism for silent synapses that coexists and unfolds at different times has also been proposed (Choi et al., 2003) . Certainly, it has been argued that synapses can be presynaptically rather than postsynaptically silent (Cousin and Evans, 2011; Ma et al., 1999a; Moulder et al., 2008; 
3.4.
Bidirectional presynaptic regulation G-protein-mediated signaling cascades and second messengers are most likely the basis for the observed presynaptic interaction of dopamine D1 and mGLU2/3 receptors. Because of our experimental design we have not tested the action of mGluR activation on D1 modified synapses themselves -the contrasting actions were recorded from different cultures. We observed that both the enhancing and inhibitory effects on release are modulated by PKA, since specific PKA antagonists prevented the effects not only of forskolin (Fig. 3) but also of specific agonists to dopamine D1 (Fig. 5 ) and mGLU2/3 (Fig. 6) receptors. The potential site of action for PKA is downstream of calcium entry affecting the release process by recruitment/ replenishment of synaptic vesicles, increase of the size of the readily releasable pool and exocytosis/fusion (Brown and Sihra, 2008) (Fig. 4) . Of course the sign of the action of PKA on release is different after D1 or mGluR treatment and so we expect different intracellular cascades to be involved in the two cases. Although the site of action of the drugs is most likely to be on the known receptors on the terminals themselves we cannot directly exclude other sites of action, such as glial cells or axonal actions. Network actions were reduced, in our experiments, by the blockade of postsynaptic receptors for glutamate with DNQX.
The participation of intracellular cascades and their crosstalk in plasticity related events has been well studied (Atwood et al. (2014) for review). Specific examples involving dopamine and mGLUR3 (Williams and Dexter, 2014) , dopamine D1 and mGLU5R (Fieblinger et al., 2014) and the bidirectional responses to dopamine D1 and mGLU2/3 receptors observed in the rat basolateral amygdala (Li and Rainnie, 2014) underline the importance of presynaptic receptormediated modulation of neurotransmitter release in plasticity, neuroprotection and brain dysfunction.
Convergence of axon terminals in close proximity provides an ideal arrangement for presynaptic interaction and an important form of control of neurotransmitter release. High affinity presynaptic receptors can be considered as detectors and regulators of neurotransmitter release to maintain a homeostatic balance when fluctuations in release change physiological states.
Experimental procedures
We used cultured neurons expressing fluorescent reporters of vesicle release: SypHx2 or iGluSnFR. A synaptic bouton was identified from confocal scanning microscope images obtained before and after field electrical neuronal stimulation via two platinum wires on either side of the cultures. Drugs were added to the circulating medium 20 min before running an automated data acquisition cycle controlled by the microscope's computer. Off-line data analysis was performed after a final strong stimulation (40 pulses, 20 Hz) was delivered to identify all release sites. A region of interest (ROI, 1 mm diameter) was set around release sites so identified and they were then separated into responsive and inactive boutons, as seen in the previous states of the experiment.
4.1.

Optical imaging
Coverslips containing cultured neurons (13-15 DIV) were mounted on a laminar flow chamber (Warner Instruments LLC, CT USA) and perfused with artificial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 2.5 mM MgCl 2 maintaned at pH 7.4 with 95% O 2 and 5% CO 2 gas. AMPA/kainate receptors were blocked with DNQX (10 mM) added to the medium. Medium was circulated at a rate of 2 ml/min (Perista Atto, Tokyo Japan) and maintained at 28 1C with a temperature controller (Warner Instruments, CT, USA). Neurons were imaged (256 Â 256 pixels at 16 Hz) using a confocal scanning microscope (Olympus). Fluorescence of release sensors (SypHx2 and iGluSnFR) or calcium indicator (G-CaMP3) was excited with an argon laser at 488 nm filtered at 510-610 nm through a 60x objective of NA 1.1 and 2.0 mm working distance. The membrane-selective marker of endocytosis dye FM4-64 (Molecular probes, OR, USA) was excited with argon laser at 543 nm and collected through a 580-680 nm filter. Throughout the experiments laser power was fixed and fluorescence intensity expressed as arbitrary fluorescent units (AFU) measured at fixed sensitivity.
A microscope computer ran data acquisition cycles that started with neuronal field stimulation triggered after a 10 s delay. Electrical field stimulation (delivered through two platinum wires attached to the culture dish) with parameters optimized according to the release reporter:-to 1 ms/ 20 mA delivered at 20 Hz for 250 ms (5 pulses) repeated every 5 s for SypHx2 and a single 1ms/ 20 mA pulse repeated four times every 10 s for iGluSnFR. When needed, stimulation cycles were repeated allowing 5 min of recovery between runs. In different experiments the following drugs were administered in ACSF (pH 7.4) in the presence of AMPA/kainate receptor antagonist DNQX (Tocris, 10 mM). Drugs obtained from Sigma: cAMP activator forskolin (10 μM), specific cell-permeable inhibitor of protein kinase A (PKA) KT5720 (200 nM), cell permeable cAMP analog 8-bromoadenosine 3', 5'-cyclic monophosphate (8-BrcAMP 100 μM), cholinergic agonist nicotine (1 mM). Drugs obtained from Tocris: analog cAMP-activated guanine exchange factor Epac, 8-(4-chlorophenylthio)À 2'-O-methyl adenosine 3',5'-cyclic monophosphate monosodium hydrate (8-pCPT-2'-O-Me-cAMP, 100 μM), dopamine D2 receptor agonist (7)-quinpirole (500 nM), protein kinase A inhibitor myristolyated PKI 14-22 amide (400 nM), group II mGlu receptor agonist LY379268 (50 nM), group II metabotropic GLU receptor antagonist LY341495 (1 mM) and D1 dopamine receptor agonist SKF 38393 hydrobromide (10 mM). To avoid drug interaction with our synapse identification, a 30 min washout following drug administration was performed before identifying responsive release sites to high frequency stimulation.
4.2.
Cell cultures Tissue was cut into smaller pieces and incubated in 0.4% DNase-1 (Sigma-Aldrich)/0.25% trypsin (Invitrogen) for 30 min in the 37 1C followed by suspension, centrifugation and re-suspension. Cells were counted under a microscope using a hemocytometer (Bright-Line, Housser Scientific, Horsham, PA). We plated neurons in NbActiv4 medium (BrainBits, LLC, UK) on 25 mm diameter coverslips pre-coated with 10 μg/ ml poly-Llysine (Sigma-Aldrich) at a density of 3 Â 10 5 cells. For the first 24 h in culture only, the NbActiv4 medium was supplemented with 5% heat-inactivated horse serum and 1% penicillin/ streptomycin. We maintained cultures in a CO 2 humidified incubator at 37 1C in NbActiv4 with 1% penicillin/streptomycin. Half of the culture medium was exchanged twice a week with new medium containing 1% penicillin/streptomycin. No measures were taken to exclude, or encourage glial cells which are present in our cultures.
Viral production
Lentiviruses were produced by triple transfection of HEK 293 T/17 cells (ATCC, VA, USA) with pLentivirus, pMD2.G and psPAX using FuGENE6 transfection reagent (Roche, Basel Switzerland) as described by (Boyden et al., 2005) with the following modifications: A total of 10 6 HEK 293 T/17 cells were seeded in 4 plates (10 cm diameter) 24 h prior transfection in Dulbecco's modified eagle medium (DMEM) (Invitrogen) supplemented with 5% fetal bovine serum, 0.075% sodium bicarbonate, 1% glutamax (Invitrogen), 1% penicillin (1 IU/ ml)/streptomycin (1 μg/ml) and 1 mM sodium pyruvate. All chemicals were obtained from Sigma, unless otherwise noted. We used a total of 7.3 mg of pLenti-syn-SypHx2 plasmid, 2.3 mg of pMD.2.G and 5 mg of psPAX for the transfection of each 10 cm dish. The precipitate was formed by adding the plasmids to 640 ml of serum-free DMEM (without supplements) for 5 min followed by 44 μl of FuGENE6 briefly mixing with a vortexer. Incubation was carried out for 15 min at room temperature and the DNA/liposomal mixture was added to culture dishes. Cultures were maintained in a CO 2 humidified incubator (Sanyo, Osaka Japan) at 37 1C. After an incubation period of 5-6 h, medium was replaced with ultraculture medium (Lonza, Basel Switzerland) supplemented with: 0.075% sodium bicarbonate, 1% glutamax, 1% penicillin (1 IU/ml)/ streptomycin (1 μg/ml), 0.5 μM sodium butyrate and 1 mM sodium pyruvate. We collected the conditioned medium containing extruded viruses after 48 h, concentrated it by ultracentrifugation and determined the viral titer using Lenti-X qRT-PCR Titration Kit (Takara, Osaka Japan).
4.4.
Viral infection
Cortical cultures were infected at 7 days-in-vitro (7 DIV) using 200x serial dilution of lentivirus including SypHx2 RNA ( $5 Â 10 7 IFU/ml), adeno-associated virus stereotype 2/1 (AAV2/1) including G-CaMP3 DNAs ( $ 1.0 Â 10 9 IFU/ml) or with AAV2/9 including iGluSnFR DNAs ( $ 1.2 Â 10 9 IFU/ml, University of Pennsylvania Vector Core) at 3 DIV. Viral dilutions were added to cortical cultures seeded on 25 mm coverslips and incubated at 37 1C for a day, after incubation culture medium was exchanged with fresh medium.
Immunohistochemistry
Cultures were fixed in 4% paraformaldehyde for 60 min at room temperature, rinsed three times with 10 mM phosphate buffered saline (PBS) and stored at 4 1C. Cultures were permeabilized and blocked in cold PBS with 0.3% tritonX-100 and 20% normal goat serum for 60 min at room temperature. After washing with PBS, cultures were incubated with primary antibodies diluted in 10 mM PBS containing 0.3% triton-X100 overnight at 4 1C. The primary antibodies were mouse anti-PSD-95 (Gilbert, #30398) and guinea pig antivesicular GLU transporter 1 (vGlut-1) (Abcam, Tokyo, Japan). After overnight incubation cultures were rinsed with 10 mM PBS. Alexa fluor 594 conjugated secondary antibodies (1:500) (Invitrogen) were incubated for 3 h at room temperature and rinsed again. Fluorescence images were obtained under confocal microscope (Olympus, Fluoview FV1000 MPE, Tokyo, Japan).
4.6.
Measurements and data analysis
Identification of synapses
We identified synapses by working in reverse through the series of images captured by the computer, using the last of the series (at 20 Hz, 40 pulses) to identify release sites and quiet sites activated over the course of treatments before the final stimulation, thereby identifying the processes that lead to sites becoming active. The off-line data analysis (Image J http://rsb.info.nih.gov/ij/) started from the last experimental condition, i.e., "identification of active synaptic boutons". Stacks of images were obtained during field stimulation five for SypHx2 and ten for iGluSnFR. Frames before and after stimulation were averaged separately and subtracted from each other to produce a differential fluorescence or ΔF image. The ΔF image was then median-filtered at 3 pixels. If boutons were not clearly observed at this point the analysis was not performed. Bright fluorescent spots in the same focal plane were used as landmarks for synaptic boutons identified during the final stimulation procedure to find release sites. The mean noise amplitude was calculated as the standard deviation of points before electrical stimulation. Ten responses to stimulation were averaged and the signal range was calculated by subtracting the average of 20 points before electrical stimulation from 10 points after electrical stimulation. If this value was greater than the standard deviation of the signals before stimulation (signal to noise value; S/N41), it was defined as an active synapse in experiments with SypHx2 (for iGluSnFR; S/N41.0 and for G-Camp3; S/N42). The region of interest (1 mm diameter) was set around responsive and silent boutons and the analysis of responses to stimulation in the presence of drugs started. The change in fluorescence from both previously inactive and previously active synapses were averaged to measure the effect of the applied drugs.
To verify the pH-sensitive response of the synaptic boutons expressing SypHx2, images were obtained while applying a solution of ammonium chloride (NH 4 Cl 50 mM) pH of 7.4 prepared by replacing NaCl (50 mM) in the standard ACSF. The lack of saturation of SypHx2 results was demonstrated by comparison with the saturated images obtained after NH 4 Cl perfusion. for 2 min
Determination of calcium dependency
To identify whether changes in calcium influx were related to the process of activating individual boutons, cortical neurons were infected with AAV expressing the calmodulinassociated fluorescence indicator GCaMP3. Images obtained with this indicator were sampled before and after forskolin administration, and then the membrane-selective marker of endocytosis FM4-64 (1 mM) was loaded and unloaded to clearly differentiate presynaptic sites from other areas of the neuron expressing GCaMP3. Neurons exposed to FM4-64 were incubated in the dark for 2 min in ACSF containing the NMDA GLU receptor antagonist D-AP5 (50 mM, Tocris, Bristol UK). To promote internalization of the dye neurons were exposed to KCl (100 mM) for 2 min. To remove external dye and reduce background staining neurons were incubated for 5 min in ACSF containing 100 mM ADVASEP-7 (Biotium, CA, USA) plus 50 mM D-AP5 followed by continued washing in the normal ACSF for 15 min. Images were acquired after washing. To verify the lack of saturation of G-CaMP3 signals the internal concentration of calcium was increased by perfusion of the calcium ionophore ionomycin (1 mM in ACSF) for 3 min and images collected at the end of experiments.
Determination of endocytosis
Endocytosis was measured by strong stimulation (40 stimuli at 20 Hz) and SypHx2 fluorescence image collection. After high frequency stimulation the decay of SypHx2 fluorescence corresponds to a sum of endocytosis and reacidification of the vesicular contents (Atluri and Ryan, 2006; Granseth et al., 2006) . Using Origin pro software (version 8.6 J) the averaged fluorescent response curves were normalized aspercent of peak fluorescence, followed by a 10-point average filter. The rate of endocytosis or τ e was calculated by applying the following formula to normalized fluorescent curves: F(t) ¼ A1*EXP(À t/τ e )þA2*EXP( À t/τ r )þΨ 0 where A1 and A2 are positive values of averaged fluorescent response amplitudes, τ e and τ r are time constants for endocytosis and reacidification respectively. Reacidification or τ r was fixed to the typical value of 4 s. A value of Ψ 0 as 0.3 provided the best fit to our data. Once τ e was calculated the adjusted R-square of F(t) greater than 0.8 confirmed the best adjustment (Atluri and Ryan, 2006; Granseth et al., 2006 ).
Determination of the readily releasable pool size (RRP)
We used the method of Ariel and Ryan (2010) to determine the size of RRP at single synapses. This method uses continuous high frequency stimulation (20 pulses at 100 Hz) to exhaust the process of exocytosis. Using a rapid line-scan mode we determined that the fluorescence plateau was reached between 10 and 20 pulses. As explained in section 4.6.1, at the end of the experiments we appliedammonium chloride (NH4Cl) for 2 min. The size of the readily releasable pool was calculated from the SypHx2 fluorescence intensity within each region of interest by subtracting 5 points before electrical field stimulation from the final 5 points after high frequency stimulation. The value of the ΔSypHx2/SypHx2 reflected the size of the RRP. We illustrate that value (Fig. 4) but we calculated SypHx2/NH 4 Cl fluorescence as used by Ariel and Ryan (2010) and obtained similar results.
Statistics
Statistical significance was tested by the t-test for paired data or with one-way analysis of variance ANOVA and post hoc multi comparison performed by the Newman-Keuls test using IGOR Pro and R software (WaveMetrics, Inc. Oregon USA versions 6.34 A and 2.14.1 respectively). Typically, data was expressed as mean7SEM (number of experiments) unless otherwise noted.
